As a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases, they are promoting research and development of anti-cancer drugs and anti-fibrotic drugs based on differentiated platform technologies of OPTIFLEX ® and PROTACTICS ®. In addition, the company is growing as a Total Healthcare Solution Provider through the CDMO business utilizing the Pharmaceutical Raw M...
As a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases, they are promoting research and development of anti-cancer drugs and anti-fibrotic drugs based on differentiated platform technologies of OPTIFLEX ® and PROTACTICS ®. In addition, the company is growing as a Total Healthcare Solution Provider through the CDMO business utilizing the Pharmaceutical Raw Materials Business Headquarters (Ansan, GMP) and Fine Chemicals Business Headquarters (Asan).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.